Healthcare Services

Increasing Adoption Of Rising Healthcare Expenditures Fuel Growth In The Drug Discovery Technologies Market Is Influencing The Drug Discovery Technologies Market

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Value Of The Drug Discovery Technologies Market Projected To Expand During 2026–2030?

The drug discovery technologies market size has experienced significant expansion in recent years. It is projected to grow from $80.76 billion in 2025 to $90.23 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The historical growth in this market is attributed to factors such as screening automation development, genomic research expansion, computational chemistry adoption, biologics research growth, and drug pipeline complexity.

The drug discovery technologies market is anticipated to show considerable growth over the next few years. It is expected to reach $138.44 billion by 2030, advancing at a compound annual growth rate (CAGR) of 11.3%. The growth during this forecast period is attributable to AI-driven molecular design, a concentrated focus on personalized medicine, the integration of advanced analytics, novel therapeutic modalities, and accelerated discovery timelines. Significant trends in the forecast period include the increasing uptake of high-throughput screening, greater deployment of bioinformatics platforms, the expansion of RNA-based drug discovery, the rising application of nanotechnology in drug design, and the incorporation of pharmacogenomics into discovery.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12715&type=smp

What Primary Factors Are Fueling The Expansion Of The Drug Discovery Technologies Market?

The expansion of the drug discovery technologies market is anticipated to be fueled by increasing healthcare spending. Healthcare expenditures encompass the complete financial resources dedicated to medical services, public health efforts, family planning, nutrition initiatives, and urgent health aid. This spending trend is upward due to greater demand for advanced treatments, an aging global demographic, the prevalence of chronic diseases, and expanded access to healthcare services. The drug discovery technologies sector leverages this increased financial commitment to improve research platforms, analytical instruments, and digital tools, thereby accelerating the development of new therapies. For example, the Office of National Statistics, a UK-based government agency, reported in May 2024 that total healthcare expenditure rose by 5.6% in nominal terms between 2022 and 2023, a significant increase compared to the 0.9% growth observed in 2022. Consequently, the upward trajectory of healthcare expenditures is a key driver for the growth of the drug discovery technologies market.

What Segment Types Are Included In The Drug Discovery Technologies Market Analysis?

The drug discovery technologies market covered in this report is segmented –

1) By Technology: High Throughput Screening, Genomics, Nanotechnology, Bioinformatics, Combinational Chemistry, Pharmacogenomics, Biochips, Bioanalytical Instruments, Ribonucleic Acid Interface (RNAI)

2) By Drug Type: Small Molecule Drugs, Biologic Drugs

3) By Disease Application: Cancer Diseases, Immunological Diseases, Neurological Diseases, Cardiovascular Diseases, Other Disease Applications

4) By End-User: Pharmaceutical Companies, Biopharmaceutical Companies, Biotechnology Companies, Research Institutes, Other End-Users

Subsegments:

1) By High Throughput Screening: Automated Screening Systems, Assay Development

2) By Genomics: DNA Sequencing, Genomic Data Analysis

3) By Nanotechnology: Nanoparticle-Based Drug Delivery, Nanomaterials For Drug Formulation

4) By Bioinformatics: Data Analysis Tools, Computational Biology Software

5) By Combinational Chemistry: Library Synthesis Techniques, Screening Methods

6) By Pharmacogenomics: Genetic Testing Platforms, Personalized Medicine Applications

7) By Biochips: Microarrays, Lab-On-A-Chip Technologies

8) By Bioanalytical Instruments: Mass Spectrometry, Chromatography Systems

9) By Ribonucleic Acid Interface (RNAI): RNA Interference Technologies, Therapeutic RNA Applications

Which Trends Are Supporting The Evolution Of The Drug Discovery Technologies Market?

Leading firms within the drug discovery technologies sector are concentrating on creating sophisticated solutions, specifically drug research and development platforms. These platforms aim to boost accuracy, improve the efficiency of high-throughput analysis, and hasten the identification of novel therapeutic agents. Such a platform represents a unified structure designed to simplify the procedures involved in finding, developing, refining, and confirming potential pharmaceutical drugs, utilizing coherent workflows and tools driven by data. As an illustration, in July 2023, Dotmatics Inc., a scientific software firm based in the US, unveiled its Small Molecule Drug Discovery Solution. This extensive R&D platform incorporates pre-set workflows and superior data management features, crafted to promote teamwork, increase output, and rationalize operational processes. The platform empowers researchers to convert data into practical knowledge effectively, establishing a unified environment from the initial stages of hit discovery to lead optimization, thereby speeding up the creation of drugs that enhance lives.

Who Are The Leading Firms Participating In The Drug Discovery Technologies Market?

Major companies operating in the drug discovery technologies market are F. Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., AstraZeneca plc., Merck KGaA, GE HealthCare Technologies Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Evotec SE, Curia Global Inc., Aragen Life Sciences Private Limited, Luminex Corporation, BioXcel Therapeutics Inc., Certara Inc., Schrödinger Inc., Sygnature Discovery Ltd., Recursion Pharmaceuticals Inc., InSilico Medicine Inc., ChemAxon Ltd., Enamine Ltd., BenevolentAI Limited, OpenEye Scientific Software Inc., Collaborative Drug Discovery Inc., Pharmacelera S.L., Gyros Protein Technologies AB, Optibrium Ltd., Cresset Group, Relay Therapeutics Inc.

Access The Complete Drug Discovery Technologies Market Report:

https://www.thebusinessresearchcompany.com/report/drug-discovery-technologies-global-market-report

Which Geographic Region Represents The Largest Drug Discovery Technologies Market Share?

North America was the largest region in the drug discovery technologies market in 2025. The regions covered in the drug discovery technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Drug Discovery Technologies Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12715&type=smp

Browse Through More Reports Similar to the Global Drug Discovery Technologies Market 2026, By The Business Research Company

Drug Discovery Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Drug Discovery Informatics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report

Drug Discovery Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795